Literature DB >> 2853303

3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes.

E Werle1, T Lenz, G Strobel, H Weicker.   

Abstract

The binding properties of 3- and 4-O-sulfo-conjugated dopamine (DA-3-O-S, DA-4-O-S) as well as 3-O-methylated dopamine (MT) to rat striatal dopamine D2 receptors were investigated. 3H-spiperone was used as a radioligand in the binding studies. In saturation binding experiments (+)butaclamol, which has been reported to bind to dopaminergic D2 and serotoninergic 5HT2 receptors, was used in conjunction with ketanserin and sulpiride, which preferentially label 5HT2 and D2 receptors, respectively, in order to discriminate between 3H-spiperone binding to D2 and to 5HT2 receptors. Under our particular membrane preparation and assay conditions, 3H-spiperone binds to D2 and 5HT2 receptors with a maximal binding capacity (Bmax) of 340 fmol/mg protein in proportions of about 75%:25% with similar dissociation constants KD (35 pmol/l; 43 pmol/l). This result was verified by the biphasic competition curve of ketanserin, which revealed about 20% high (KD = 24 nmol/l) and 80% low (KD = 420 nmol/l) affinity binding sites corresponding to 5HT2 and D2 receptors, respectively. Therefore, all further competition experiments at a tracer concentration of 50 pmol/l were performed in the presence of 0.1 mumol/l ketanserin to mask the 5HT2 receptors. DA competition curves were best fitted assuming two binding sites, with high (KH = 0.12 mumol/l) and low (KL = 18 mumol/l) affinity, present in a ratio of 3:1. The high affinity binding sites were interconvertible by 100 mumol/l guanyl-5-yl imidodiphosphate [Gpp(NH)p], resulting in a homogenous affinity state of DA receptors (KD = 2.8 mumol/l).2+ off

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853303     DOI: 10.1007/bf00168808

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  47 in total

1.  Sulfoconjugated catecholamines: lack of beta-adrenoceptor binding and adenylate cyclase stimulation in human mononuclear leukocytes.

Authors:  G L Michel; T Lenz; U Lernhardt; H Weicker; W P Bieger; E Werle
Journal:  Eur J Pharmacol       Date:  1987-11-10       Impact factor: 4.432

2.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

Review 3.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

4.  Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.

Authors:  M W Hamblin; S E Leff; I Creese
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

5.  Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.

Authors:  D R Howlett; S R Nahorski
Journal:  Life Sci       Date:  1980-02-18       Impact factor: 5.037

6.  Restricted alpha- and beta-adrenoceptor affinity of sulfoconjugated catecholamines in human mononuclear leukocytes, platelets, and fat cells and reduction of the postreceptor mechanisms.

Authors:  E Werle; G Michel; T Lenz; H Kather; B Schneider; H Weicker
Journal:  Int J Sports Med       Date:  1988-08       Impact factor: 3.118

7.  Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H)spiperone.

Authors:  D G Morgan; J O Marcusson; C E Finch
Journal:  Life Sci       Date:  1984-06-18       Impact factor: 5.037

8.  Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.

Authors:  S Urwyler; R Markstein
Journal:  J Neurochem       Date:  1986-04       Impact factor: 5.372

9.  Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.

Authors:  S Urwyler; D Coward
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

10.  Unequivocal synthesis and characterisation of dopamine 3- and 4-O-sulphates.

Authors:  B A Osikowska; J R Idle; F J Swinbourne; P S Sever
Journal:  Biochem Pharmacol       Date:  1982-07-01       Impact factor: 5.858

View more
  3 in total

1.  Sulfation modification of dopamine in brain regulates aggregative behavior of animals.

Authors:  Bing Chen; Xiwen Tong; Xia Zhang; Wanying Gui; Guoming Ai; Lihua Huang; Ding Ding; Jiangxu Zhang; Le Kang
Journal:  Natl Sci Rev       Date:  2021-09-02       Impact factor: 23.178

Review 2.  Specificity and impact of adrenergic projections to the midbrain dopamine system.

Authors:  Carlos A Mejias-Aponte
Journal:  Brain Res       Date:  2016-01-26       Impact factor: 3.252

3.  Permeation of Dopamine Sulfate through the Blood-Brain Barrier.

Authors:  Tina Suominen; T Petteri Piepponen; Risto Kostiainen
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.